These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 2531146

  • 1. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR, Satyamurthy N, Huang SC, Keen RE, Nissenson CH, Hoffman JM, Ackermann RF, Bahn MM, Mazziotta JC, Phelps ME.
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [Abstract] [Full Text] [Related]

  • 2. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC, Bahn MM, Barrio JR, Hoffman JM, Satyamurthy N, Hawkins RA, Mazziotta JC, Phelps ME.
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [Abstract] [Full Text] [Related]

  • 3. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM, Huang SC, Hawkins RA, Satyamurthy N, Hoffman JM, Barrio JR, Mazziotta JC, Phelps ME.
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [Abstract] [Full Text] [Related]

  • 4. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH, Laufer P, Stöcklin G, Wienhard K, Pawlik G, Böcher-Schwarz HG, Heiss WD.
    Life Sci; 1987 Jan 05; 40(1):81-8. PubMed ID: 2948091
    [Abstract] [Full Text] [Related]

  • 5. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH, Wienhard K, Stöcklin G, Laufer P, Hebold I, Pawlik G, Heiss WD.
    Eur J Nucl Med; 1988 Jan 05; 14(2):80-7. PubMed ID: 2968911
    [Abstract] [Full Text] [Related]

  • 6. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
    Swart JA, van der Werf JF, Wiegman T, Paans AM, Vaalburg W, Korf J.
    J Cereb Blood Flow Metab; 1990 May 05; 10(3):297-306. PubMed ID: 1970341
    [Abstract] [Full Text] [Related]

  • 7. In vitro pharmacological profile of 3-N-(2-fluoroethyl)spiperone.
    Goffinet AM, Leysen J, Labar D.
    J Cereb Blood Flow Metab; 1990 Jan 05; 10(1):140-2. PubMed ID: 2137131
    [Abstract] [Full Text] [Related]

  • 8. The quantitative analysis of D2-dopamine receptors in baboon striatum in vivo with 3-N-[2'-18F]fluoroethylspiperone using positron emission tomography.
    Jovkar S, Wienhard K, Pawlik G, Coenen HH.
    J Cereb Blood Flow Metab; 1990 Sep 05; 10(5):720-6. PubMed ID: 2384543
    [Abstract] [Full Text] [Related]

  • 9. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM, Ansari MS, Schmidt DE, de Paulis T, Clanton JA, Innis R, al-Tikriti M, Manning RG, Gillespie D.
    Life Sci; 1991 Sep 05; 49(8):617-28. PubMed ID: 1830917
    [Abstract] [Full Text] [Related]

  • 10. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr 05; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 11. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M.
    Nucl Med Biol; 1999 Jul 05; 26(5):519-27. PubMed ID: 10473190
    [Abstract] [Full Text] [Related]

  • 12. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding.
    Perlmutter JS, Moerlein SM, Hwang DR, Todd RD.
    J Neurosci; 1991 May 05; 11(5):1381-9. PubMed ID: 1827499
    [Abstract] [Full Text] [Related]

  • 13. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2.
    Hatano K, Ishiwata K, Kawashima K, Hatazawa J, Itoh M, Ido T.
    J Nucl Med; 1989 Apr 05; 30(4):515-22. PubMed ID: 2567779
    [Abstract] [Full Text] [Related]

  • 14. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B, Grigoriadis DE, DeSouza EB.
    J Pharmacol Exp Ther; 1992 Sep 05; 262(3):929-35. PubMed ID: 1356154
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
    Lever JR, Scheffel UA, Stathis M, Musachio JL, Wagner HN.
    Life Sci; 1990 Sep 05; 46(26):1967-76. PubMed ID: 2362552
    [Abstract] [Full Text] [Related]

  • 16. 4-[123I]iodospiperone as a ligand for dopamine DA receptors: in vitro and in vivo experiments in a rat model.
    Van der Krogt JA, Pauwels EK, Van Doremalen PA, Wijnhoven G, Reiffers S, Van Valkenburg CF, Buruma OJ.
    Int J Rad Appl Instrum B; 1992 Oct 05; 19(7):759-63. PubMed ID: 1399697
    [Abstract] [Full Text] [Related]

  • 17. No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography.
    Satyamurthy N, Bida GT, Barrio JR, Luxen A, Mazziotta JC, Huang SC, Phelps ME.
    Int J Rad Appl Instrum B; 1986 Oct 05; 13(6):617-24. PubMed ID: 3494003
    [Abstract] [Full Text] [Related]

  • 18. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL, Largent BL, Snyder SH.
    Life Sci; 1984 Nov 05; 35(19):1981-8. PubMed ID: 6149442
    [Abstract] [Full Text] [Related]

  • 19. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A, Neve KA, Kinzie JM, Taylor B, de Paulis T, Belknap JK.
    J Pharmacol Exp Ther; 1992 Jun 05; 261(3):1282-90. PubMed ID: 1534844
    [Abstract] [Full Text] [Related]

  • 20. Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a PET study.
    Moresco RM, Colombo C, Fazio F, Bonfanti A, Lucignani G, Messa C, Gobbo C, Galli L, Del Sole A, Lucca A, Smeraldi E.
    Neuroimage; 2000 Oct 05; 12(4):452-65. PubMed ID: 10988039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.